Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myeloma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myeloma
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-03-02
DOI
10.1038/s41598-018-22130-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Immunology of CD1- and MR1-Restricted T Cells
- (2016) Lucia Mori et al. Annual Review of Immunology
- Daratumumab, Elotuzumab, and the Development of Therapeutic Monoclonal Antibodies in Multiple Myeloma
- (2016) JP Laubach et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Human MAIT-cell responses to Escherichia coli : activation, cytokine production, proliferation, and cytotoxicity
- (2016) Joana Dias et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Spontaneous onset and transplant models of the Vk*MYC mouse show immunological sequelae comparable to human multiple myeloma
- (2016) Rachel E. Cooke et al. Journal of Translational Medicine
- MAIT cells reside in the female genital mucosa and are biased towards IL-17 and IL-22 production in response to bacterial stimulation
- (2016) A Gibbs et al. Mucosal Immunology
- The intracellular pathway for the presentation of vitamin B–related antigens by the antigen-presenting molecule MR1
- (2016) Hamish E G McWilliam et al. NATURE IMMUNOLOGY
- MAIT cells are activated during human viral infections
- (2016) Bonnie van Wilgenburg et al. Nature Communications
- Advances and practical use of monoclonal antibodies in multiple myeloma therapy
- (2016) H. C. Lee et al. Hematology-American Society of Hematology Education Program
- Circulating and tumor-infiltrating mucosal associated invariant T (MAIT) cells in colorectal cancer patients
- (2016) Limian Ling et al. Scientific Reports
- Cereblon binding molecules in multiple myeloma
- (2015) K.M. Kortüm et al. BLOOD REVIEWS
- IL-15 dependent induction of IL-18 secretion as a feedback mechanism controlling human MAIT-cell effector functions
- (2015) Arne Sattler et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients
- (2015) Isabelle Magalhaes et al. JOURNAL OF CLINICAL INVESTIGATION
- Altered Distribution and Increased IL-17 Production by Mucosal-Associated Invariant T Cells in Adult and Childhood Obesity
- (2015) Eirin Carolan et al. JOURNAL OF IMMUNOLOGY
- PD-L1/PD-1 presence in the tumor microenvironment and activity of PD-1 blockade in multiple myeloma
- (2015) B Paiva et al. LEUKEMIA
- Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group
- (2015) J Laubach et al. LEUKEMIA
- Innate-like T cell profile in myeloma: Severe deficiency of Vγ9Vδ2 T cells in aminobisphosphonate-treated patients
- (2015) Mairéad Walsh et al. LEUKEMIA & LYMPHOMA
- The burgeoning family of unconventional T cells
- (2015) Dale I Godfrey et al. NATURE IMMUNOLOGY
- Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma
- (2015) Sagar Lonial et al. NEW ENGLAND JOURNAL OF MEDICINE
- Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection
- (2015) Edwin Leeansyah et al. PLoS Pathogens
- Adoptive T Cell Therapy Targeting CD1 and MR1
- (2015) Tingxi Guo et al. Frontiers in Immunology
- Altered CD161bright CD8+ Mucosal Associated Invariant T (MAIT)-Like Cell Dynamics and Increased Differentiation States among Juvenile Type 1 Diabetics
- (2015) Robert Z. Harms et al. PLoS One
- PDL1 Expression on Plasma and Dendritic Cells in Myeloma Bone Marrow Suggests Benefit of Targeted anti PD1-PDL1 Therapy
- (2015) Anne-Marit Sponaas et al. PLoS One
- Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases
- (2014) N.-E. Serriari et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients
- (2014) C. Blimark et al. HAEMATOLOGICA
- A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells
- (2014) Sidonia B.G. Eckle et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mucosal-Associated Invariant T Cell Deficiency in Systemic Lupus Erythematosus
- (2014) Young-Nan Cho et al. JOURNAL OF IMMUNOLOGY
- MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets
- (2014) A Kurioka et al. Mucosal Immunology
- T-cell activation by transitory neo-antigens derived from distinct microbial pathways
- (2014) Alexandra J. Corbett et al. NATURE
- The Decrease in Number and Change in Phenotype of Mucosal-Associated Invariant T cells in the Elderly and Differences in Men and Women of Reproductive Age
- (2014) J. Novak et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- The Rise and Fall of MAIT Cells with Age
- (2014) L. J. Walker et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Natural killer T cell defects in multiple myeloma and the impact of lenalidomide therapy
- (2013) A. C. Chan et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections
- (2013) David Grimaldi et al. INTENSIVE CARE MEDICINE
- Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells
- (2013) Rangsima Reantragoon et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Rapid and Unidirectional Perforin Pore Delivery at the Cytotoxic Immune Synapse
- (2013) J. A. Lopez et al. JOURNAL OF IMMUNOLOGY
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- (2013) Michael S. Lawrence et al. NATURE
- The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
- (2013) G. Lu et al. SCIENCE
- Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance
- (2013) C Bryant et al. Blood Cancer Journal
- MAIT Cells Detect and Efficiently Lyse Bacterially-Infected Epithelial Cells
- (2013) Lionel Le Bourhis et al. PLoS Pathogens
- Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection
- (2012) E. Leeansyah et al. BLOOD
- Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma
- (2012) J. Richter et al. BLOOD
- MR1 presents microbial vitamin B metabolites to MAIT cells
- (2012) Lars Kjer-Nielsen et al. NATURE
- Co-dependents: MR1-restricted MAIT cells and their antimicrobial function
- (2012) Marielle C. Gold et al. NATURE REVIEWS MICROBIOLOGY
- Drugs: More shots on target
- (2011) Adrianne Appel NATURE
- Multiple Myeloma
- (2011) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells
- (2010) M. Dusseaux et al. BLOOD
- Antimicrobial activity of mucosal-associated invariant T cells
- (2010) Lionel Le Bourhis et al. NATURE IMMUNOLOGY
- Human Mucosal Associated Invariant T Cells Detect Bacterially Infected Cells
- (2010) Marielle C. Gold et al. PLOS BIOLOGY
- Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma
- (2009) H Quach et al. LEUKEMIA
- Stepwise Development of MAIT Cells in Mouse and Human
- (2009) Emmanuel Martin et al. PLOS BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now